摘要
Is there a need for small molecule neuroprotectants in inherited retinal degeneration(iRDs)?iRDs are a heterogeneous cluster of diseases which lead to blindness in 1 in every 2–3000 people.A plethora of causative genetic defects were revealed in the last 30years.Current research focuses on development of pharmacological,biological or mechanical implant treatments.Gene
Is there a need for small molecule neuroprotectants in inherited retinal degeneration （iRDs）？ iRDs are a heterogeneous cluster of diseases which lead to blindness in 1 in every 2-3000 people. A plethora of causative genetic defects were revealed in the last 30 years. Current research focuses on development of pharmacolog- ical, biological or mechanical implant treatments.
基金
received funding from the Science Foundation Ireland/Enterprise Ireland(SFI/EI)Technology Innovation Development Award(TIDA)grant No.17/TIDA/4993
the European Union’s Horizon 2020 research and innovation programme under grant agreement No.734907(RISE/3D-NEONET project)
